Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kate Young"'
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
In 2014, the survival benefits seen in REGARD and RAINBOW studies led the way for the regulatory approval of ramucirumab in the second line setting in oesophagogastric (OG) cancer. Trials of other drugs targeting the vascular endothelial growth facto
Externí odkaz:
https://doaj.org/article/377678f1989248998b09fae34e5b4613
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
In 2014, the survival benefits seen in REGARD and RAINBOW studies led the way for the regulatory approval of ramucirumab in the second line setting in oesophagogastric (OG) cancer. Trials of other drugs targeting the vascular endothelial growth facto